Printed From:

What is Adlyxin?

Adlyxin is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of Use:

  • Has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis.
  • Not for treatment of type 1 diabetes or diabetic ketoacidosis.
  • Has not been studied in combination with short acting insulin.
  • Has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis.

How does Adlyxin Work?

Adlyxin is a GLP‐1 receptor agonist. Adlyxin increases glucose‐dependent insulin release, decreases glucagon secretion, and slows gastric emptying.

Pay no more than $0*

if enrolled in the Sanofi Rx Savings program and taking select Sanofi diabetes products.

Pay no more than $15 if new to the program.*

*Restrictions apply.

Get Personalized Patient Support

The Adlyxin COACH program provides information and personalized support for patients who have been prescribed Adlyxin.